Gynest (Estriol 0.01%)
intravaginal cream is licensed for hormone replacement therapy for treatment of atrophic vaginitis and
kraurosis in post-menopausal women. It is also licensed for the treatment of
pruritus vulvae and dyspareunia associated with atrophic vaginal epithelium.
